Stockscreener 앱 받기
4.00
4.76%
-0.20
시장 영업 전:
4.08
0.08
+2.00%
전일 마감가:
$4.20
열려 있는:
$4.2
하루 거래량:
4.56M
Relative Volume:
0.82
시가총액:
$1.47B
수익:
$4.09M
순이익/손실:
$-660.15M
주가수익비율:
-1.7351
EPS:
-2.3053
순현금흐름:
$-117.10M
1주 성능:
-7.62%
1개월 성능:
+5.54%
6개월 성능:
-10.71%
1년 성능:
+172.11%
1일 변동 폭
$3.945
$4.23
1주일 범위
$3.945
$4.35
52주 변동 폭
$1.29
$6.75
Ataibeckley Inc Stock (ATAI) Company Profile
명칭
Ataibeckley Inc
전화
1 929 207 2670
주소
C/O ATAI LIFE SCIENCES US, INC., NEW YORK
Compare ATAI vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ATAI
Ataibeckley Inc
|
4.00 | 1.47B | 4.09M | -660.15M | -117.10M | -2.3053 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Ataibeckley Inc Stock (ATAI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-27 | 개시 | Deutsche Bank | Buy |
| 2026-01-20 | 개시 | Guggenheim | Buy |
| 2025-10-13 | 개시 | Needham | Buy |
| 2025-07-29 | 개시 | Oppenheimer | Outperform |
| 2024-11-18 | 재확인 | H.C. Wainwright | Buy |
| 2024-04-03 | 업그레이드 | Maxim Group | Hold → Buy |
| 2022-11-01 | 개시 | Loop Capital | Buy |
| 2021-11-30 | 개시 | Maxim Group | Buy |
| 2021-11-11 | 개시 | ROTH Capital | Buy |
| 2021-10-18 | 개시 | H.C. Wainwright | Buy |
| 2021-09-01 | 개시 | Jefferies | Buy |
| 2021-07-13 | 개시 | Berenberg | Buy |
| 2021-07-13 | 개시 | Canaccord Genuity | Buy |
| 2021-07-13 | 개시 | Cantor Fitzgerald | Buy |
| 2021-07-13 | 개시 | Citigroup | Buy |
| 2021-07-13 | 개시 | Cowen | Outperform |
| 2021-07-13 | 개시 | Credit Suisse | Outperform |
| 2021-07-13 | 개시 | RBC Capital Mkts | Sector Perform |
| 2021-07-08 | 개시 | Aegis Capital | Buy |
모두보기
Ataibeckley Inc 주식(ATAI)의 최신 뉴스
ATAI stock soars on track for best day on Trump psychedelics push and Wall Street cheers - MSN
Is AtaiBeckley (ATAI) Redefining Its Psychedelic Strategy With Standalone EMP-01 Anxiety Data? - simplywall.st
10 Health Care Stocks With Whale Alerts In Today's SessionAbbVie (NYSE:ABBV), AtaiBeckley (NASDAQ:ATAI - Benzinga
Does AtaiBeckley’s (ATAI) EMP-01 Data Hint At A Scalable MDMA Therapy Platform? - Yahoo Finance
Ataibeckley: Anxiety drug cuts social phobia symptoms by 38% - MSN
ATAI Stock Price, Quote & Chart | ATAIBECKLEY INC (NASDAQ:ATAI) - ChartMill
These stocks are today’s movers: Fermi, AST SpaceMobile, Intel, Marvell, USA Rare Earth, Ataibeckley, and more - MSN
Why Ataibeckley stock surged today - MSN
Atai Beckley N.V. (ATAI) Receives a Buy from H.C. Wainwright - The Globe and Mail
AtaiBeckley weighing options for lead psychedelic therapy: Bloomberg - MSN
Shroom stocks rise as Trump is said to sign executive order on psychedelic drug - MSN
Psychedelic stocks soar as Trump signs order to ease access - MSN
Small cap wrap: VivoPower, First Phosphate, ataiBeckley, Trillion Energy... - Proactive financial news
AtaiBeckley wins OVID Health Silver Award for patient partnership in psychedelic trials - Proactive Investors
Cybin stands out as the most undervalued psychedelic stock as Trump signs on faster PTSD research - MSN
AtaiBeckley and PsyPAN Receive a Silver Award in 2026 Patient Participant Index, Reflecting Ongoing Commitment to Participant-Informed Research - Investing News Network
AtaiBeckley and PsyPAN win silver for trial participant input - Stock Titan
AtaiBeckley bets on next-gen psychedelic medicines to transform mental health - Proactive financial news
Enveric Biosciences surges over 90%, other psychedelic stocks soar in Monday pre-market: What's going on? - MSN
AtaiBeckley Inc.Common Stock (NQ: ATAI - The Chronicle-Journal
AtaiBeckley’s EMP-01 Data Strengthen Case For Psychedelic Anxiety Pipeline - Sahm
ATAI Stock Soars On Track For Best Day On Trump Psychedelics Push And Wall Street Cheers - Stocktwits
Ataibeckley Inc (ATAI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.14%
0.48%
자본화:
|
볼륨(24시간):